Pitcairn Co. grew its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 11.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 2,684 shares of the financial services provider’s stock after acquiring an additional 282 shares during the period. Pitcairn Co.’s holdings in CME Group were worth $578,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. B. Riley Wealth Advisors Inc. boosted its stake in shares of CME Group by 1.3% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC lifted its stake in CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after purchasing an additional 48 shares during the last quarter. Lantz Financial LLC lifted its stake in CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after purchasing an additional 49 shares during the last quarter. Transcend Capital Advisors LLC lifted its stake in CME Group by 1.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after purchasing an additional 50 shares during the last quarter. Finally, Greystone Financial Group LLC lifted its stake in CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after purchasing an additional 52 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on CME. Deutsche Bank Aktiengesellschaft reduced their price objective on CME Group from $195.00 to $193.00 and set a “hold” rating on the stock in a research note on Thursday. Morgan Stanley raised their price objective on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Keefe, Bruyette & Woods raised their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday. Rosenblatt Securities restated a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Finally, Barclays raised their target price on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research note on Thursday. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $212.64.
Insider Activity
In other news, CEO Terrence A. Duffy sold 40,000 shares of the firm’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the transaction, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Terrence A. Duffy sold 40,000 shares of CME Group stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the transaction, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 54,290 shares of company stock valued at $11,393,700. Company insiders own 0.30% of the company’s stock.
CME Group Stock Performance
CME stock opened at $199.38 on Friday. The stock has a market capitalization of $71.79 billion, a price-to-earnings ratio of 22.68, a PEG ratio of 6.57 and a beta of 0.52. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80. The stock’s fifty day moving average is $200.12 and its two-hundred day moving average is $206.93.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period last year, the company earned $2.30 earnings per share. On average, research analysts predict that CME Group Inc. will post 9.75 EPS for the current year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date was Friday, June 7th. CME Group’s dividend payout ratio (DPR) is 52.33%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- ETF Screener: Uses and Step-by-Step Guide
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.